Among them, we identified that PD-1 expression in tumor-infiltrating lymphocytes was HIF-1α dependent, an important observation given that PD-1 identifies the patient-specific CD8+ tumor-reactive TIL repertoire (Gros et al., 2014). This evidence concerns the gene CD8A and neoplasm.